Seoul National University Hospital clinical trial pipeline

17 trials changed in the last 30 days: 0 stopped, 5 with notable changes, 12 with minor changes only.

1. Notable

   Window of Opportunity Trial of Neoadjuvant Olaparib and Durvalumab…Window of Opportunity Trial of Neoadjuvant Olaparib and Durvalumab for Triple Negative or Low ER+ Breast Cancer

   Primary and study completion pushed from Dec 31, 2025 to Dec 31, 2026

   Seoul National University Hospital·Phase 1/2· NCT03594396· Registry history of NCT03594396 on ClinicalTrials.gov (opens the registry)

   Oct 19, 2026

2. Notable

   Eleveld PK/PD Model-based Dosing During General Anesthesia

   Recruitment opened

   Seoul National University Hospital·Phase 4· NCT07675850· Registry history of NCT07675850 on ClinicalTrials.gov (opens the registry)

   Sep 29, 2026

3. Notable

   Intravenous Dexamethasone With Single-Shot Versus Continuous…Intravenous Dexamethasone With Single-Shot Versus Continuous Brachial Plexus Block for Rebound Pain After Shoulder Surgery

   Recruitment opened

   Seoul National University Hospital·Phase 4· NCT07699744· Registry history of NCT07699744 on ClinicalTrials.gov (opens the registry)

   Sep 29, 2026

4. Notable

   Proactive Immune Tolerance Induction in Chemotherapy for…Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer

   Recruitment opened

   Seoul National University Hospital·Not applicable· NCT06977594· Registry history of NCT06977594 on ClinicalTrials.gov (opens the registry)

   Oct 7, 2026

5. Notable

   DeepUSFF · Quantitative Ultrasound (RS85 and R20) for Liver Fat…DeepUSFF · Quantitative Ultrasound (RS85 and R20) for Liver Fat Quantification in MASLD Using MRI-PDFF as Reference

   Enrollment increased: 62 → 182 participants

   Also in this update: Enrollment closed, study ongoing; Study completion pushed from Jun 30, 2026 to Dec 30, 2026

   Seoul National University Hospital·Not applicable· NCT07192159· Registry history of NCT07192159 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.